KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE

Disclosed are kinase inhibitor compounds having the following structure: (I), or a stereoisomer, pharmaceutically acceptable salt, oxide, or solvate thereof, where R1, R2, R3, R4, R5, R6, N-Ar, X, Y, Z, and AA are as defined herein. Also disclosed are compositions containing the kinase inhibitor com...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DEVITA, Robert J, KUMAR, Kunal, SANCHEZ, Roberto J, WANG, Hui, WANG, Peng, SUEBSUWONG, Chalada, STEWART, Andrew F
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator DEVITA, Robert J
KUMAR, Kunal
SANCHEZ, Roberto J
WANG, Hui
WANG, Peng
SUEBSUWONG, Chalada
STEWART, Andrew F
description Disclosed are kinase inhibitor compounds having the following structure: (I), or a stereoisomer, pharmaceutically acceptable salt, oxide, or solvate thereof, where R1, R2, R3, R4, R5, R6, N-Ar, X, Y, Z, and AA are as defined herein. Also disclosed are compositions containing the kinase inhibitor compounds, methods of inhibiting activity of a kinase in a cell, methods of increasing cell proliferation in a population of pancreatic beta cells, methods of treating a subject for a condition associated with insufficient insulin secretion, and methods of treating a subject for a neurological disorder.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2022064146A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2022064146A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2022064146A13</originalsourceid><addsrcrecordid>eNrjZLDz9vRzDHZV8PTz8HTyDPEPUnD29w3wD_VzCVZw9HOB8II9Qzz9_SACvq4hHv5ASX83hdBgVx4G1rTEnOJUXijNzaDs5hri7KGbWpAfn1pckJicmpdaEh8abGRgZGRgZmJoYuZoaEycKgAJgisN</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE</title><source>esp@cenet</source><creator>DEVITA, Robert J ; KUMAR, Kunal ; SANCHEZ, Roberto J ; WANG, Hui ; WANG, Peng ; SUEBSUWONG, Chalada ; STEWART, Andrew F</creator><creatorcontrib>DEVITA, Robert J ; KUMAR, Kunal ; SANCHEZ, Roberto J ; WANG, Hui ; WANG, Peng ; SUEBSUWONG, Chalada ; STEWART, Andrew F</creatorcontrib><description>Disclosed are kinase inhibitor compounds having the following structure: (I), or a stereoisomer, pharmaceutically acceptable salt, oxide, or solvate thereof, where R1, R2, R3, R4, R5, R6, N-Ar, X, Y, Z, and AA are as defined herein. Also disclosed are compositions containing the kinase inhibitor compounds, methods of inhibiting activity of a kinase in a cell, methods of increasing cell proliferation in a population of pancreatic beta cells, methods of treating a subject for a condition associated with insufficient insulin secretion, and methods of treating a subject for a neurological disorder.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220303&amp;DB=EPODOC&amp;CC=US&amp;NR=2022064146A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220303&amp;DB=EPODOC&amp;CC=US&amp;NR=2022064146A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DEVITA, Robert J</creatorcontrib><creatorcontrib>KUMAR, Kunal</creatorcontrib><creatorcontrib>SANCHEZ, Roberto J</creatorcontrib><creatorcontrib>WANG, Hui</creatorcontrib><creatorcontrib>WANG, Peng</creatorcontrib><creatorcontrib>SUEBSUWONG, Chalada</creatorcontrib><creatorcontrib>STEWART, Andrew F</creatorcontrib><title>KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE</title><description>Disclosed are kinase inhibitor compounds having the following structure: (I), or a stereoisomer, pharmaceutically acceptable salt, oxide, or solvate thereof, where R1, R2, R3, R4, R5, R6, N-Ar, X, Y, Z, and AA are as defined herein. Also disclosed are compositions containing the kinase inhibitor compounds, methods of inhibiting activity of a kinase in a cell, methods of increasing cell proliferation in a population of pancreatic beta cells, methods of treating a subject for a condition associated with insufficient insulin secretion, and methods of treating a subject for a neurological disorder.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLDz9vRzDHZV8PTz8HTyDPEPUnD29w3wD_VzCVZw9HOB8II9Qzz9_SACvq4hHv5ASX83hdBgVx4G1rTEnOJUXijNzaDs5hri7KGbWpAfn1pckJicmpdaEh8abGRgZGRgZmJoYuZoaEycKgAJgisN</recordid><startdate>20220303</startdate><enddate>20220303</enddate><creator>DEVITA, Robert J</creator><creator>KUMAR, Kunal</creator><creator>SANCHEZ, Roberto J</creator><creator>WANG, Hui</creator><creator>WANG, Peng</creator><creator>SUEBSUWONG, Chalada</creator><creator>STEWART, Andrew F</creator><scope>EVB</scope></search><sort><creationdate>20220303</creationdate><title>KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE</title><author>DEVITA, Robert J ; KUMAR, Kunal ; SANCHEZ, Roberto J ; WANG, Hui ; WANG, Peng ; SUEBSUWONG, Chalada ; STEWART, Andrew F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2022064146A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>DEVITA, Robert J</creatorcontrib><creatorcontrib>KUMAR, Kunal</creatorcontrib><creatorcontrib>SANCHEZ, Roberto J</creatorcontrib><creatorcontrib>WANG, Hui</creatorcontrib><creatorcontrib>WANG, Peng</creatorcontrib><creatorcontrib>SUEBSUWONG, Chalada</creatorcontrib><creatorcontrib>STEWART, Andrew F</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DEVITA, Robert J</au><au>KUMAR, Kunal</au><au>SANCHEZ, Roberto J</au><au>WANG, Hui</au><au>WANG, Peng</au><au>SUEBSUWONG, Chalada</au><au>STEWART, Andrew F</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE</title><date>2022-03-03</date><risdate>2022</risdate><abstract>Disclosed are kinase inhibitor compounds having the following structure: (I), or a stereoisomer, pharmaceutically acceptable salt, oxide, or solvate thereof, where R1, R2, R3, R4, R5, R6, N-Ar, X, Y, Z, and AA are as defined herein. Also disclosed are compositions containing the kinase inhibitor compounds, methods of inhibiting activity of a kinase in a cell, methods of increasing cell proliferation in a population of pancreatic beta cells, methods of treating a subject for a condition associated with insufficient insulin secretion, and methods of treating a subject for a neurological disorder.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2022064146A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T01%3A55%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DEVITA,%20Robert%20J&rft.date=2022-03-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2022064146A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true